# U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies.

*biotech · news · 2026-04-02 · MarketScreener*

## Key points

- Sixteen major pharmaceutical companies agreed to 'most-favoured-nation' drug pricing for U.S. consumers.
- TrumpRx.gov will enable direct-to-consumer drug sales with discounts up to 85% from companies such as Pfizer.
- Novo Nordisk will reduce Ozempic and Wegovy monthly prices from over $1,000 to $350 through TrumpRx.
- Bristol Myers Squibb will provide Eliquis free to Medicaid and donate its active ingredient as part of the deal.
- Regeneron is the only company among 17 major firms not yet to sign such an agreement.

**Companies:** PFIZER, JOHNSON & JOHNSON, ASTRAZENECA, NOVO NORDISK, ELI LILLY, ABBVIE, BRISTOL MYERS SQUIBB, GILEAD SCIENCES, MERCK, ROCHE, NOVARTIS, AMGEN, SANOFI, GSK, BOEHRINGER INGELHEIM, REGENERON
**Countries:** United States, Germany

[Read the full story on MarketScreener](https://www.marketscreener.com/news/global-pharma-companies-that-have-publicly-announced-trump-drug-pricing-agreements-ce7e51ddda8cf72c)

---

Canonical: https://newsio.io/n/bc8f16c6-660f-45e4-97d3-9c6d3f7bcb79/u-s-president-donald-trump-secured-agreements-with-16-major-pharmaceutical-compa
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works